Drug General Information
Drug ID	D05CND
Former ID	DNC005403
Drug Name	6-(3-Nitro-phenyl)-3H-benzothiazol-2-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[527672]
Structure		Download 2D MOL 3D MOL
Formula	C13H8N2O3S
Canonical SMILES	C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC3=C(C=C2)NC(=O)S3
InChI	1S/C13H8N2O3S/c16-13-14-11-5-4-9(7-12(11)19-13)8-2-1-3-10(6-8)15(17)18/h1-7H,(H,14,16)
InChIKey	NGWRFPUBBONZGG-UHFFFAOYSA-N
PubChem Compound ID	10221123
Target and Pathway
Target(s)	Progesterone receptor	Target Info	Inhibitor	[527672]
KEGG Pathway	Oocyte meiosis
	Progesterone-mediated oocyte maturation
Pathway Interaction Database	Cellular roles of Anthrax toxin
Reactome	Nuclear signaling by ERBB4
	Nuclear Receptor transcription pathway
WikiPathways	Ovarian Infertility Genes
	Signaling by ERBB4
	Nuclear Receptors
References
Ref 527672	J Med Chem. 2005 Aug 11;48(16):5092-5.Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potentand selective nonsteroidal progesterone receptor agonist tanaproget.
Ref 527672	J Med Chem. 2005 Aug 11;48(16):5092-5.Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potentand selective nonsteroidal progesterone receptor agonist tanaproget.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.